Safety and Usability Evaluation Study of FFI-1010 Single Administration for Children Under 18 Years Old With Kidney Disease (Phase III Study)
Latest Information Update: 17 Dec 2019
At a glance
- Drugs FFI 1010 (Primary)
- Indications Kidney disorders
- Focus Registrational; Therapeutic Use
- Sponsors Fuji Yakuhin
Most Recent Events
- 17 Dec 2019 New trial record